Subscribe
About

Partnership for biomedical innovation

Lezette Engelbrecht
By Lezette Engelbrecht, ITWeb online features editor
Johannesburg, 03 Jun 2010

Partnership for biomedical innovation

Sanofi-Aventis has formed a strategic alliance with the Massachusetts Institute of Technology (MIT) Centre for Biomedical Innovation in the US to advance knowledge of human health through research and to promote scientific exchange between the company and MIT, says Pharma Times.

The partnership, to be known as the Sanofi-Aventis Biomedical Innovation Programme, will support a number of activities over the next three years by granting 'biomedical innovation funding awards'. The focus will be on nanotechnology and biologic-based drug therapies, with the aim of providing integrated, patient-focused healthcare options.

Claude Canizares, VP for research and associate provost at MIT, said: “We are seeing an incredible convergence of research talent, with engineers working side by side with molecular biologists and scientists and also to some extent with our economists and managerial experts, who are thinking about healthcare from many points of view.”

Imaging tech targets breast cancer

New imaging technology is being tested to improve detection of small tumours in dense breast tissue and provide new options in addition to mammography, reports Hospital News.

GE Healthcare commercialised the technology, which uses an imaging device and a molecular probe tagged with a radioactive isotope to detect tumours.

The probe targets and lights up the tumours and makes them visible with the use of a special camera. The procedure involves an injection of the probe and a scan with the molecular breast imaging device.

EHSI designs medication app for seniors

Emerging Healthcare Solutions is developing a new iPhone app to dramatically reduce medication errors for senior citizens, states Market Watch.

Millions of seniors in America take a confusing array of medications to improve their quality of life. When they forget to take their medications or confuse dosage and administration times, they suffer.

EHSI's new 'Auto-Med' application is being designed to automatically call users every day to remind them at the precise time of exactly what medication and dosage they are to take based upon their doctor's recommendation.

Share